Heterogeneity in head and neck IMRT target design and clinical practice
- PMID: 22405806
- PMCID: PMC3694728
- DOI: 10.1016/j.radonc.2012.02.010
Heterogeneity in head and neck IMRT target design and clinical practice
Abstract
Purpose: To assess patterns of H&N IMRT practice with particular emphasis on elective target delineation.
Materials and methods: Twenty institutions with established H&N IMRT expertise were solicited to design clinical target volumes for the identical H&N cancer case. To limit contouring variability, a primary tonsil GTV and ipsilateral level II node were pre-contoured. Participants were asked to accept this GTV, and contour their recommended CTV and PTV. Dose prescriptions, contouring time, and recommendations regarding chemotherapy were solicited.
Results: All 20 institutions responded. Remarkable heterogeneity in H&N IMRT design and practice was identified. Seventeen of 20 centers recommended treatment of bilateral necks whereas 3/20 recommended treatment of the ipsilateral neck only. The average CTV volume was 250 cm(3) (range 37-676 cm(3)). Although there was high concordance in coverage of ipsilateral neck levels II and III, substantial variation was identified for levels I, V, and the contralateral neck. Average CTV expansion was 4.1mm (range 0-15 mm). Eight of 20 centers recommended chemotherapy (cisplatin), whereas 12/20 recommended radiation alone. Responders prescribed on average 69 and 68 Gy to the tumor and metastatic node GTV, respectively. Average H&N target volume contouring time was 102.5 min (range 60-210 min).
Conclusion: This study identifies substantial heterogeneity in H&N IMRT target definition, prescription, neck treatment, and use of chemotherapy among practitioners with established H&N IMRT expertise. These data suggest that continued efforts to standardize and simplify the H&N IMRT process are desirable for the safe and effective global advancement of H&N IMRT practice.
Copyright © 2012 Elsevier Ireland Ltd. All rights reserved.
Conflict of interest statement
None of the authors has a conflict of interest regarding the work presented in this manuscript.
Figures
References
-
- Huang TL, Tsai WL, Chien CY, et al. Quality of life for head and neck cancer patients treated by combined modality therapy: the therapeutic benefit of technological advances in radiotherapy. Qual Life Res. 2010;9:1243–54. - PubMed
-
- Gregoire V, Levendag P, Ang KK, et al. Ct-based delineation of lymph node levels and related CTVs in the node-negative neck: DAHANCA, EORTC, GORTEC, NCIC, Rtog consensus guidelines. Radiother Oncol. 2003;69:227–36. - PubMed
-
- Levendag P, Braaksma M, Coche E, et al. Rotterdam and brussels ct-based neck nodal delineation compared with the surgical levels as defined by the American Academy of Otolaryngology-Head and Neck Surgery. Int J Radiat Oncol Biol Phys. 2004;58:113–23. - PubMed
-
- Nowak PJ, Wijers OB, Lagerwaard FJ, Levendag PC. A three-dimensional CT-based target definition for elective irradiation of the neck. Int J Radiat Oncol Biol Phys. 1999;45:33–9. - PubMed
-
- Ang KK, Garden AS. Radiotherapy for head and neck cancers: indications and techniques. 4. Philadelphia, PA: Lippincott Williams & Wilkins; 2011.
Publication types
MeSH terms
Grants and funding
LinkOut - more resources
Full Text Sources
Medical
